JMJ Pharma SRL
1.8 FTEJMJ Pharma reported total assets of 850,094 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026), with 1.8 full-time equivalent.
The score of JMJ Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets -18 % Headcount (avg FTE) -36 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JMJ Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 1,900 € | ||||
| Equity | 111,605 € | ||||
| Cash | 14,950 € | ||||
| EBITDA | 76,068 € | ||||
| Total assets | 850,094 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
JMJ Pharma's financial analysis
- Solvency13.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JMJ Pharma
JMJ Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0766.337.513
- VAT number
- BE0766337513
- Peppol
- Registered · 0208:0766337513 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Apr 2021
- Registered office
- 1350 Orp-Jauche
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
JMJ Pharma (SRL) has been based in Orp-Jauche since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,900 € and equity of 111,605 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.1%, below the median of its sector (41.5%).
Companies similar to JMJ Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Guilmin - Lambeau Retail sale of pharmaceutical products Wavre · balance sheet 850,468 €
- Hove Pharma Retail sale of pharmaceutical products Hove · balance sheet 849,286 €
- Apotheek Schuttershof Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 849,063 €
- Pharmathus Retail sale of pharmaceutical products Aubange · balance sheet 845,919 €
- I-Phanet Retail sale of pharmaceutical products Dour · balance sheet 854,717 €
- Fevery-Dewitte Retail sale of pharmaceutical products Bruges · balance sheet 856,740 €
- Bruyaux Pharma Retail sale of pharmaceutical products Mons · balance sheet 856,915 €
- Pasmans-Mertens Retail sale of pharmaceutical products Brasschaat · balance sheet 842,675 €
Frequently asked questions about JMJ Pharma
What is the revenue of JMJ Pharma?
JMJ Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JMJ Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0766337513 for JMJ Pharma, if the company is VAT-registered. Its company number (CBE) is 0766.337.513.
Where is the registered office of JMJ Pharma?
According to the CBE register, the registered office of JMJ Pharma is in 1350 Orp-Jauche.
What is the equity of JMJ Pharma?
At the close of the 2025 financial year, the equity of JMJ Pharma amounts to 111,605 €, a solvency of 13.1% of total assets.
How many people work at JMJ Pharma?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages JMJ Pharma?
The register lists 1 active mandates at JMJ Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JMJ Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →